Death Reported From Sanofi-Aventis (SASY.PA) Novel Antibiotic, Ketek; Sanofi Down After FDA Alert
WASHINGTON - Researchers reported Friday three cases of severe liver problems, including one death, in patients at a North Carolina hospital after they began taking a novel antibiotic. Federal regulators said they were reviewing an unknown number of U.S. cases involving the drug, telithromycin, and were consulting with their counterparts overseas.